Mini Review
Published on 16 May 2022
Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations
in Rheumatology
- 2,378 views
- 5 citations